Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjun Mahajan

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Rheumatology (Oxford, England)|December 26, 2025
Belimumab versus calcineurin inhibitors for cancer risk in lupus nephritisArjun Mahajan, Alessandra Tomasi, Matthew A Sparks, et al.
Journal of Autism and Developmental Disorders|March 9, 2022
Opportunities for Inclusion and Engagement in the Transition of Autistic Youth from Pediatric to Adult Healthcare: A Qualitative StudyJennifer L Ames, Arjun Mahajan, Meghan N Davignon, et al.
Journal of the American Academy of Dermatology|June 24, 2026
Evaluating Skin Tone Bias in Multimodal Large Language Models for Autoimmune and Immune-Mediated Skin DiseasesArjun Mahajan, Maureen Whittelsey, Keyarah Grullon, et al.
Rheumatology (Oxford, England)|March 24, 2025
Rituximab vs cyclophosphamide for cancer risk in ANCA-associated vasculitisArjun Mahajan, Martin Viola, Jacob Ellen, et al.
Annals of Maxillofacial Surgery|September 15, 2023
Oral Manifestations of Malignant Immunoglobinopathy Hidden in Plain Sight - A Rare Case ReportNaresh Kumar Sharma, Akhilesh Kumar Singh, Mehul Shashikant Hirani, et al.
Journal of the American Academy of Dermatology|April 9, 2026
Rituximab versus Mycophenolate Mofetil or Azathioprine for Cancer Risk in Pemphigus: a TriNetX-based Emulated Target TrialArjun Mahajan, Avery H LaChance, Nathaniel S Treister, et al.
Journal of Maxillofacial and Oral Surgery|October 8, 2024
Novel Tripartite Classification for Fractures of Coronoid Process of Mandible: A Retrospective Tertiary Center StudyArjun Mahajan, Akhilesh Kumar Singh, Naresh Kumar Sharma, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 12, 2026
Rituximab versus Cyclophosphamide for IgA VasculitisArjun Mahajan, Sharon A Chung, Jennifer E Yeh, et al.
JAAD Case Reports|December 10, 2024
Pembrolizumab-induced Stevens-Johnson syndrome-like reaction: An atypical clinical presentationArjun Mahajan, Ryan Chen, Grant M Fischer, et al.
The Journal of Rheumatology|December 15, 2025
Rituximab Versus Mycophenolate Mofetil for Infection Risk in Systemic SclerosisArjun Mahajan, Maureen Whittelsey, Nikki Zangenah, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Rheumatology (Oxford, England)|December 26, 2025
Belimumab versus calcineurin inhibitors for cancer risk in lupus nephritisArjun Mahajan, Alessandra Tomasi, Matthew A Sparks, et al.
Journal of Autism and Developmental Disorders|March 9, 2022
Opportunities for Inclusion and Engagement in the Transition of Autistic Youth from Pediatric to Adult Healthcare: A Qualitative StudyJennifer L Ames, Arjun Mahajan, Meghan N Davignon, et al.
Journal of the American Academy of Dermatology|June 24, 2026
Evaluating Skin Tone Bias in Multimodal Large Language Models for Autoimmune and Immune-Mediated Skin DiseasesArjun Mahajan, Maureen Whittelsey, Keyarah Grullon, et al.
Rheumatology (Oxford, England)|March 24, 2025
Rituximab vs cyclophosphamide for cancer risk in ANCA-associated vasculitisArjun Mahajan, Martin Viola, Jacob Ellen, et al.
Annals of Maxillofacial Surgery|September 15, 2023
Oral Manifestations of Malignant Immunoglobinopathy Hidden in Plain Sight - A Rare Case ReportNaresh Kumar Sharma, Akhilesh Kumar Singh, Mehul Shashikant Hirani, et al.
Journal of the American Academy of Dermatology|April 9, 2026
Rituximab versus Mycophenolate Mofetil or Azathioprine for Cancer Risk in Pemphigus: a TriNetX-based Emulated Target TrialArjun Mahajan, Avery H LaChance, Nathaniel S Treister, et al.
Journal of Maxillofacial and Oral Surgery|October 8, 2024
Novel Tripartite Classification for Fractures of Coronoid Process of Mandible: A Retrospective Tertiary Center StudyArjun Mahajan, Akhilesh Kumar Singh, Naresh Kumar Sharma, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 12, 2026
Rituximab versus Cyclophosphamide for IgA VasculitisArjun Mahajan, Sharon A Chung, Jennifer E Yeh, et al.
JAAD Case Reports|December 10, 2024
Pembrolizumab-induced Stevens-Johnson syndrome-like reaction: An atypical clinical presentationArjun Mahajan, Ryan Chen, Grant M Fischer, et al.
The Journal of Rheumatology|December 15, 2025
Rituximab Versus Mycophenolate Mofetil for Infection Risk in Systemic SclerosisArjun Mahajan, Maureen Whittelsey, Nikki Zangenah, et al.
Pageof 6